Edition:
United States

Mirati Therapeutics Inc (MRTX.PH)

MRTX.PH on Philadelphia Stock Exchange

4.00USD
1:51pm EDT
Change (% chg)

$0.12 (+3.23%)
Prev Close
$3.88
Open
$3.90
Day's High
$4.00
Day's Low
$3.90
Volume
1,600
Avg. Vol
451
52-wk High
$7.19
52-wk Low
$2.75

MRTX.PH

Chart for MRTX.PH

About

Mirati Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing a pipeline of targeted oncology products. The Company's clinical pipeline consists of three product candidates: MGCD265, MGCD516 and mocetinostat. MGCD265 and MGCD516 are orally-bioavailable, spectrum-selective kinase... (more)

Overall

Beta: 1.32
Market Cap(Mil.): $94.77
Shares Outstanding(Mil.): 24.94
Dividend: --
Yield (%): --

Financials

  MRTX.PH Industry Sector
P/E (TTM): -- 239.63 19.01
EPS (TTM): -3.80 -- --
ROI: -78.59 -8.17 -5.03
ROE: -78.75 -11.48 -4.28

BRIEF-Broadfin Capital LLC reports 6.90 pct passive stake in Mirati Therapeutics Inc as of Jan 6, 2017

* Broadfin Capital LLC reports 6.90 percent passive stake in Mirati Therapeutics Inc as of January 6, 2017 - Sec Filing Source text (http://bit.ly/2ibJ1uN) Further company coverage:

Jan 09 2017

BRIEF-Mirati Therapeutics announces pricing of public offering of common stock

* Pricing of underwritten public offering of 4.4 million shares of common stock at a price to public of $5.60 per share

Jan 06 2017

BRIEF-Mirati Therapeutics announces pricing of public offering of common stock

* Mirati Therapeutics announces pricing of public offering of common stock

Jan 06 2017

More From Around the Web

Earnings vs. Estimates